The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
Abstract
Class I major histocompatibility complex (MHC) molecules present antigens that are produced within the presenting cell or penetrate from the vacuolar system into the cytosol for processing. Most studies of exogenous antigen processing have used soluble antigens, which are not efficiently presented by class I MHC molecules and do not elicit CD8 T-cell responses in vivo. But particulate antigen preparations with no known mechanism for cytosolic penetration can also elicit CD8 T-cell responses in vivo. We report here that phagocytosis of bacteria with no mechanism for cytosolic penetration also results in presentation of bacterial antigens by class I MHC molecules. Moreover, this mechanism is resistant to cycloheximide and Brefeldin A, which block the classical class I processing pathway. These results suggest a novel vacuolar class I processing pathway for exogenous phagocytic antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We demonstrate that bacterial HLA-I and HLA-II peptides can be presented by both antigen-presenting cells (as has previously been shown25–28) and by melanoma cells”
From Identification of bacteria-derived HLA-bound peptides in melanoma (2021) · cites this paper as [26]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,421
Bevan, M. J. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.143.5.1283 · Cited by 984
Fibronectin binding mediated by a novel class of surface organelles on Escherichia coll
Olsén, A., Jonsson, A., & Normark, S. J. (1989) · Nature · doi:10.1038/338652a0 · Cited by 614
Self-citationSequence of chicken ovalbumin mRNA
McReynolds, L. A., O’Malley, B. W., Nisbet, A. D., Fothergill, J. E., Givol, D., Fields, S., Robertson, M., & Brownlee, G. G. (1978) · Nature · doi:10.1038/273723a0 · Cited by 435
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F., & Bevan, M. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.377 · Cited by 400
Promoters largely determine the efficiency of repressor action.
Lanzer, M., & Bujard, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8973 · Cited by 362
Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
Rock, K. L., Gamble, S., & Rothstein, L. (1990) · Science · doi:10.1126/science.2392683 · Cited by 335
Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes
Braciale, T. J., Morrison, L. A., Sweetser, M. T., Sambrook, J., Gething, M.-J. H., & Braciale, V. L. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00521.x · Cited by 320
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F., & Bevan, M. J. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.603 · Cited by 220
Sarmiento, M., Dialynas, D. P., Lancki, D. W., Wall, K. A., Lorber, M. I., Loken, M. R., & Fitch, F. W. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb01063.x · Cited by 210
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 611
Current Thoughts on the Therapeutic Potential of Stem Cell
Rameshwar, P. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-815-3_1 · Cited by 6
Rammensee, H., Bachmann, J., & Stevanović, S. (1997) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22162-4_4 · Cited by 5
Curing Metastases? Gene and Peptide Therapy
Eisenbach, L. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80071-9_6 · Cited by 5
Caulada-Benedetti, Z., Vecchio, L. C., Pardi, C. C. A., Massironi, S. M. G., Lima, M. R. D., & Abrahamsohn, I. A. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00063-7 · Cited by 5
Interactions of viruses with dendritic cells
Larsson, M., Fonteneau, J., Lee, A. W.-T., & Bhardwaj, N. (2001) · Elsevier eBooks · doi:10.1016/b978-012455851-9/50075-4 · Cited by 5
The Delivery of Extracellular “Danger” Signals to Cytosolic Sensors in Phagocytes
Gonzales, G. A., & Canton, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.944142 · Cited by 4
Development of Dendritic Cell Membrane-Coated Nanoparticles for Antigen-Specific T-Cell Engagement
Puth, S., Jadhav, S. S., Zareein, A., Blauser-Wilson, J., Mahmoudi, M., Betanzos, R. R., Ventura, B., Sprague-Getsy, A. M., Hu, X., Hougland, J. L., et al. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01234 · Cited by 4
WDFY4-dependent cross-presentation proceeds via a vacuolar antigen-processing route
Postoak, J. L., Koch, A., Shan, S., Ohara, R. A., Jo, S., Chen, J., Desai, P., Ou, F., Kraft, M., Diamond, M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519922122 · Cited by 4
“A vacuolar model emerged from various studies of macrophages reporting that antigens could be cross-presented without degradation by cytosolic proteasomes or involvement of the TAP transporters (8, 17), implying the possibility of a vesicular route.”
An Update on the Therapeutic Potential of Stem Cells
Rameshwar, P., Moore, C. A., Shah, N. N., & Smith, C. P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8697-2_1 · Cited by 4
Naik, U., & Harrison, R. E. (2013) · Colloquium Series on Building Blocks of the Cell Cell Structure and Function · doi:10.4199/c00081ed1v01y201304bbc004 · Cited by 3
Dendritic Cells and Their Role in Linking Innate and Adaptive Immune Responses
Lipscomb, M. F., Wilder, J. A., & Masten, B. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_2 · Cited by 4
Abdel‐Motal, U. M., Dahmén, J., Liu, T., Ljunggren, H., & Jondal, M. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02637-5 · Cited by 4
Synthetic Peptide Vaccines Effective in Preventing Virus Infection
Ogasawara, K. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb03352.x · Cited by 4
Endothelial Cell-Mediated Antigen Presentation
Johnson, D. R. (2006) · Transfusion Medicine and Hemotherapy · doi:10.1159/000090195 · Cited by 4
Development of Intracellular Drug Delivery System Using Fusogenic Liposomes
Yoshikawa, T., Okada, N., & Nakagawa, S. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.789 · Cited by 4
Presenting Exogenous Antigen to T Cells
Harding, C. V. (1997) · Current Protocols in Immunology · doi:10.1002/0471142735.im1602s23 · Cited by 4
“CD8+ class I MHC–restricted T hybridomas generally secrete IL-2 upon antigen recognition, and IL-2 secretion can be quantitated as a measure of antigen presentation following the approach used for CD4+ T hybridoma detection of peptide–class II MHC complexes (Pfeifer et al., 1993).”
BackgroundSelf-citationImmune Reactions Towards Biopharmaceuticals – a General, Mechanistic Overview
Foged, C., & Sundblad, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-75841-1_1 · Cited by 4
Ringrose, J. H., Yard, B. A., Verjans, G. M. G. M., & Boog, C. J. P. (1996) · Clinical Rheumatology · doi:10.1007/bf03342653 · Cited by 4
“Alternatively, Harding et al (28) propose that for exogenou s antigens, MHC class I loading takes place either in the endo-lysosomal compartment or at the cell surface.”
BackgroundMessing with Signal 1: How Perturbed MHC Class I Antigen Presentation Contributes to Cancer
Lawand, M., Rayess, S. A., Jaber, R., & Endert, P. V. (2026) · Cells · doi:10.3390/cells15070653 · Cited by 3
The Biology of Major Histocompatibility Complex Molecules—II: Antigen Processing and Presentation
Peh, C. A., Purcell, A. W., & McCluskey, J. (2000) · Elsevier eBooks · doi:10.1016/b978-012440315-4/50079-3 · Cited by 3
Zhang, Z., Chen, X., Li, B., Xia, T., Wu, X., & Wu, C. (2023) · Helicobacter · doi:10.1111/hel.13005 · Cited by 3
Antigen Processing and Presentation
Nagy, Z. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416974-6.00007-7 · Cited by 3
Engineering cross-presentation in vivo
Chattergoon, M. A., Shames, J. P., & Weiner, D. B. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.6.887 · Cited by 3
“One group of models suggests a vacuolar and/or TAP-1- and -2-independent mechanism, in which exogenous Ags do not enter the cytosol of the DC, but rather bind to MHC class I either within post-Golgi vacuolar compartments (derived either from recycling MHC class I from the cell’s surface or from de novo synthesis) or d…”
BackgroundResultBecker, P. D., & Guzmán, C. A. (2004) · Transfusion Medicine and Hemotherapy · doi:10.1159/000082484 · Cited by 3
Donato, L., de la Salle, H., Hanau, D., Albrech, C., Oswald, M., Vandevenne, A., & Tongio, M. M. (1997) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(97)80035-4 · Cited by 3
Hermann, E. (1995) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749509100929 · Cited by 3
Kirby, L. A., Jin, J., Cardona, J. G., Smith, M. D., Martin, K. A., Wang, J., Strasburger, H. J., Herbst, L., Alexis, M., Karnell, J. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/461434 · Cited by 3
Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma
Ong, C. J., Wong, C. H. Y., Roberts, C. R., Teh, H., & Jirik, F. R. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09 · Cited by 164
Cross-presentation-based nanovaccine for cancer immunotherapy
Chaitanya, T. S., Patil, S. N., Ghosh, S., Pal, J. K., Yuba, E., & Gupta, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823686-4.00015-x · Cited by 2
Distinct Pathways for Constitutive Endocytosis of Fully Conformed and Non‐conformed Ld Molecules
Mahmutefendić, H., Kučić, N., & Lučin, P. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01134.x · Cited by 2
Peptide ligand structure influences the exchange of 2-microglobulin by cell surface K b
Cook, J. R., Myers, N. B., & Hansen, T. H. (1998) · Molecular Immunology · doi:10.1016/s0161-5890(98)00080-7 · Cited by 2
Antigen cross-presentation by macrophages
Malyshev, I. Y., Kuznetsova, L. V., Чернышова, О. О., Буданова, О. П., & Bakhtina, L. Y. (2021) · Nauchno-prakticheskii zhurnal «Patogenez» · doi:10.25557/2310-0435.2021.03.14-23 · Cited by 2
“coli, в которых экспрессируется овальбумин, активирует выработку IL-2 (маркер активации) Т-клетками линии B3Z CD8+, распознающей овальбумин [16].”
InfluentialCell‐Penetrating Peptides for Cytosolic Delivery of Biomacromolecules
Foged, C., Jing, X., & Nielsen, H. M. (2010) · Wiley eBooks · doi:10.1002/9780470875780.ch22 · Cited by 2
Ellefson, D. D., van der Velden, A. W. M., Parker, D. C., & Heffron, F. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)26073-4 · Cited by 2
T Cell Subsets and Defense against Bacteria and Viruses
Kaufmann, S. H. E., & Reddehase, M. J. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-653955-4.50013-0 · Cited by 2
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Hayakawa, T., & Mayumi, T. (1998) · Drug Delivery System · doi:10.2745/dds.13.27 · Cited by 2
Microneedles for Gene Therapy: Overcoming Extracellular and Intracellular Barriers
Cole, G., Dunne, N., & McCarthy, H. O. (2018) · Wiley eBooks · doi:10.1002/9781119305101.ch5 · Cited by 2
Antigen Presentation to Lymphocytes
Muharemagic, D., Scott, W., & Mishto, M. (2019) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0001227.pub3 · Cited by 2
Enantiomeric histidine-rich peptide coacervates enhance antigen delivery to T cellsPreprint
Pramanik, U., Das, A., Brown, E. M., Struckman, H. L., Wang, H., Stealey, S. T., Sprunger, M. L., Wasim, A., Fascetti, J. L., Mondal, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.10.612317 · Cited by 2
Chapter 1 The lysosome: Its role in the biology of the cell and organism
Storrie, B. (1996) · Principles of medical biology · doi:10.1016/s1569-2582(05)80032-7 · Cited by 1
Gleason, S. M. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Parasite-Host Interaction: A New Point of View on Immune Regulation
Stunžėnas, V. (2001) · Acta Zoologica Lituanica · doi:10.1080/13921657.2001.10512478 · Cited by 1
“APCs stimulate immune cell reactions against Ags if they are presented on the MHC I (Rock et al., 1990, 1993; Pfeifer et al., 1993; Mazzaccaro et al., 1996), the MHC II (Shen et al.”
BackgroundLi, C., Takeo, M., Matsuda, M., Nagai, H., Sun, X., Hatanaka, W., Kishimura, A., Inoue, H., Tani, K., Mori, T., et al. (2017) · MedChemComm · doi:10.1039/c7md00188f · Cited by 1
Isolation of T cells and establishment of T-cell lines and clones
Märker‐Hermann, E., & Duchmann, R. (2002) · Methods in microbiology · doi:10.1016/s0580-9517(02)32107-x · Cited by 1
Polypeptide Release from Lysosomes
Isenman, L. D. (1996) · Springer eBooks · doi:10.1007/978-1-4684-6462-7_5 · Cited by 1
Chiarella, A. D. P. (2003) · doi:10.11606/d.9.2003.tde-05032015-150715 · Cited by 1
MHC Class I Antigen Processing System
Yewdell, J. W. (2010) · doi:10.1002/9780470688618.taw0102 · Cited by 1
Characterization and immunogenicity of the heat shock protein, hsp60 of Brucella abortus
Gor, D. O. (1994) · doi:10.31274/rtd-180813-10325 · Cited by 1
Vaccination against diarrheal disease
Hale, T. L. (1993) · Clinical Immunology Newsletter · doi:10.1016/0197-1859(93)90029-j · Cited by 1
The Evolution of Anti-Tumor Immunotherapy
Imaeda, S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292070 · Cited by 1
Exosomes in immune regulation and allergy
Admyre, C. (2007) · Figshare · Cited by 1
Bacterial peptidoglycan in rheumatoid arthritis and multiple sclerosis
Schrijver, I. A. (2000) · RePub (Erasmus University Rotterdam) · Cited by 1
The various roles of invariant chain in the act of antigen Presentation
Nordeng, T. W., Simonsen, A., & Bakke, O. (1996) · Springer eBooks · doi:10.1007/978-3-642-61126-1_3 · Cited by 1
He, Y. O. (2000) · VTechWorks (Virginia Tech) · Cited by 1
Bruijn, M. L. H. D., Schuurhuis, D. H., Vermeulen, H., de Cock, K., & Melief, C. J. M. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9966-8_36 · Cited by 1
Binding and Uptake of Single and Dual-opsonized Target Particles by Macrophages
Naik, U. (2020) · TSpace (University of Toronto) · Cited by 1
Sarkouh, R. A. (2012) · theses.fr (ABES) · doi:10.70675/2b1719c1za8f2z4f96zaf7bz6f24e944ef21 · Cited by 1
Role of small GTPase Rab32 in CD8+ T cell cross-priming by conventional type 1 Dendritic Cells
Tandon, N. (2020) · theses.fr (ABES) · doi:10.70675/f5b3e394zb14ez46bdz9495z7b854182cc25 · Cited by 1
Immunogenicity of pluripotent stem cells and their differentiation products
Monecke, S. (2013) · doi:10.53846/goediss-3881 · Cited by 1
Khatib, A., Nip, J., Fallavollita, L., Lehmann, M., Jensen, G. S., & Brodt, P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999 · Cited by 15
T cell responses in reactive and Lyme arthritis
Sieper, J., & Braun, J. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8823-3_9
“However, it has been shown in humans or mice that the ReA-triggering bacteria Yersinia [39,40], Salmonella [ 41 ], and Chlamydia [42, 43, 44] can also induce a CD8+ T cell response.”
BackgroundAntigen presentation. How sweet
Boes, M. L., & Bogaert, D. (2010)
Crossprocessing and Crosspresentation
Škoberne, M., & Bhardwaj, N. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch22
Cross-Presentation by Dendritic Cells: Rolein HIV Immunity and Pathogenesis
Marañón, C., Hoeffel, G., ClaireRipoche, A., & Hosmalin, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_13
Fc γ receptors and the complement system in T cell activation
de Jong, I. J. (2007)
Processing and presentation of exogenous antigen by dendritic cells
Chen, L. (2006) · Figshare
Selective secretion by lysosomes
Isenman, L. D. (1995) · Membrane protein transport · doi:10.1016/s1874-592x(06)80021-1
Schneeberger, A., Goos, M., Stingl, G., & Wagner, S. N. (2001) · Springer eBooks · doi:10.1007/978-3-642-56441-3_14
Toll-like Receptors - Link between Innate and Adaptive Immunity
Braedel-Ruoff, S. (2007)
Role of NK cells in DC-based immunotherapy of melanoma
Bouwer, A. L. (2011) · Otago University Research Archive (University of Otago)
Bazan, S. B. (2011) · Publications of the UdS (Saarland University) · doi:10.22028/d291-22748
“The vacuolar pathway seems to be Brefeldin A-insensitive (Harding and Song, 1994; Pfeifer et al., 1993), since peptides associate with recycling class I molecules in phagocytic vacuoles or after “regurgitation” and recapture of processed antigens (Harding and Song, 1994; Norbury et al.”
BackgroundMolecular Structure and Immune Recognition of Mycobacteria
Rees, A. D. M., Mehlert, A., & Lamb, J. R. (1994) · Springer eBooks · doi:10.1007/978-94-011-1430-1_2
Arboleda, J. F., García, L. F., & Álvarez, C. M. (2011) · Biomédica · doi:10.7705/biomedica.v31i2.308
“Además de estas vías clásicas, algunos antígenos exógenos pueden escapar de la vía endocítica (por ejemplo, por fagocitosis de células apoptóticas), ser degradados por el proteasoma y cargados en las moléculas CMH de clase I, fenómeno que se conoce como “presentación cruzada” (29).”
BackgroundDevelopment of tumor vaccine therapy using .GAMMA.-PGA nanoparticles as an antigen delivery carrier
Matsuo, K., Yoshikawa, T., Okada, N., & Nakagawa, S. (2008) · Drug Delivery System · doi:10.2745/dds.23.130
Induction of Anti-Tumour Immune Responses by Dendritic Cells Generated with Flt3-Ligand
Lim, S. N. (2011) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16998700.v1
Golding, H., Zaitseva, M. B., Lapham, C. K., & Golding, B. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0062-3_9
Unraveling mechanisms behind cross presentation during phagocytic signaling
Hari, A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28591
ANALYSIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ANTIGENS PRESENTATION BY MACROPHAGES
Alatery, A. (2010) · QSpace (Queen's University Library)
Development of Fusogenic Liposomes and Its Application for Vanccine
Akira, H., & Mayumi, T. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46842-5_24
Regulation of SNARE proteins in macrophages by colony stimulating factor-1
Achuthan, A. A. (2007) · Minerva Access (University of Melbourne)
Generation of CD8+ T cell immunity with help from CD4+ T cells
Li, M. (2017) · Figshare · doi:10.4225/03/59ca0eb693c84
tovirus-infected non-haematopoietic cells requires presentation of exogenous antigen
Sigal, L. J., Crotty, S., Andino, R., & Rock, K. L. (1999)
Khurana, M. (2013) · The Medicine Forum
MHC class I and II pathways for presentation and cross-presentation of bacterial antigens
Bougnères, L., & Guermonprez, P. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541551.004
Reiser, M. L. (2011) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2324
Ugrinović, S., Mertz, A. K. H., Lauster, R., & Sieper, J. (1997) · Elsevier eBooks · doi:10.1016/b978-012459460-9/50038-x
Analysis of the basis for induction and maintenance of T cell responses in DNA vaccination.
Akbari, O. (1999) · UCL Discovery (University College London)
Identification and Characterization of Rab39a and Its Role in Crosspresentation
Cruz, F. M. (2017) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2gg6k
“Other forms of antigen, such as bacteria, have been described to follow a similar route (46, 47).”
BackgroundPathogenesis of Reactive Arthritis
Sieper, J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03622-1.50027-6
Localization of self antigen: Implications for antigen presentation to T cells
Grant, C. F. (1994) · UCL Discovery (University College London)
Synthesis of peptide conjugates with vitamins for induction of antigen‐specific immunotolerance
Yuzuriha, K., Yoshida, A., Li, S., Kishimura, A., Mori, T., & Katayama, Y. (2020) · Journal of Peptide Science · doi:10.1002/psc.3275
Increasing the potency of dendritic cell based vaccines for the treatment of cancer
Sika‐Paotonu, D. (2014) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17142863
Obermaier, B. (2005) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.4523
Metadata
- Authors
- Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Nature
- Published
- 1993-01
- Volume
- 361
- Issue
- 6410
- Pages
- 359-362
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042470561
- Cited by
- 615
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 8 · 2017: 9 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 22.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- MHC class I, antigen processing, phagocytosis, bacterial antigens, CD8+ T cells, exogenous antigen presentation, cycloheximide resistance, particulate antigen
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Antigens, Bacterial, Bacterial Proteins, Escherichia coli, Macrophages, Mice, Inbred CBA, Mice, Inbred C57BL, Microscopy, Electron, Molecular Sequence Data, Ovalbumin, Phagocytosis, Recombinant Fusion Proteins, Salmonella typhimurium, T-Lymphocytes, Vacuoles, Histocompatibility Antigens Class I, T-Lymphocyte Subsets, CD8 Antigens, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review